The authors proved that serum MMP-2 may be a marker for the evaluation of ALS progress, while serum MT-MMP-1 and MMP-9 could be useful in distinguishing ALS patients from healthy population. This evidence concerns the gene MCAT and amyotrophic lateral sclerosis.